Use of immune checkpoint inhibitors for cancer was associated with a significant reduction in actinic keratoses in a small study. The effect was greatest in younger patients and those with a history ...

Cancer immunotherapy has transformed modern oncology by harnessing body's own immune system to combat malignant disease.

Please provide your email address to receive an email when new articles are posted on . Treatment with any immune checkpoint inhibitor increased venous thromboembolism risk for adults with metastatic ...

The most robust evidence to date shows that people with a type of lung cancer lived longer if they received immunotherapy before 3pm ...

New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint ...

Please provide your email address to receive an email when new articles are posted on . Education about immune-related adverse events associated with checkpoint inhibitor therapy for cancer is ...

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA (nogapendekin alfa inbakicept) clinical program in non-small cell lung ...

Combining standard adjuvant chemotherapy with an immune checkpoint inhibitor (atezolizumab) leads to a significant improvement in disease-free survival in a subset of patients with stage 3 colon ...

In a meta-analysis of solid organ transplant recipients with advanced cancer taking immune checkpoint inhibitors, half of patients died and 1 in 5 experienced graft loss. In solid organ transplant ...

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...